“…Individual, social and environmental factors also contribute to MSD, stigma and loss of quality of life in MO patients (Nath, 2019; Sharman et al., 2016). Although MO treatment has focused on diet, physical exercise and drugs (Baillot, Mampuya, Comeau, Méziat‐Burdin, & Langlois, 2013; Srivastava & Apovian, 2018), bariatric surgery has been shown to be a reliable method of loss of weight improving quality of life (Kabu & Özbayır, 2019; Wingfield et al., 2016), body image and sexual functioning (Bates et al., 2019; Quinn‐Nilas, Benson, Milhausen, Buchholz, & Goncalves, 2016). Men with MO, driven by loss of mobility, confidence and self‐esteem, try to be included in a bariatric surgery programme (Wu & Berry, 2018), whose inclusion criteria are as follows: being an adult with a BMI ≥40 kg/m 2 ; or being an adult with a BMI of 35–39.9 kg/m 2 and having associated chronic conditions (type 2 diabetes, hypertension, hyperlipidemia) (Landecho, Valentí, Moncada, & Frühbeck, 2017; Sabench et al., 2017).…”